Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 13, 2020 16:15 ET | Source: 10x Genomics, Inc.

10x Genomics to Report Third Quarter Financial Results on November 10, 2020

PLEASANTON, Calif., Oct. 13, 2020 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the third quarter 2020 after market close on Tuesday, November...
October 05, 2020 16:15 ET | Source: 10x Genomics, Inc.

10x Genomics Advances into Emerging Field of In Situ Analysis with Two Acquisitions

PLEASANTON, Calif., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Continuing on its mission of mastering biology to advance human health, 10x Genomics, Inc. (Nasdaq: TXG) today announced that it has entered...
September 15, 2020 16:25 ET | Source: 10x Genomics, Inc.

10x Genomics Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

PLEASANTON, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (NASDAQ: TXG) (the “Company”) today announced the closing of its public offering of 4,600,000 shares of its Class A common...
September 15, 2020 08:00 ET | Source: 10x Genomics, Inc.

10x Genomics First to Market With Product to Simultaneously Capture Epigenome and Transcriptome

PLEASANTON, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it has begun shipping its Chromium Single Cell Multiome ATAC + Gene Expression solution to...
September 10, 2020 23:16 ET | Source: 10x Genomics, Inc.

10x Genomics Announces Pricing of Upsized Public Offering

PLEASANTON, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (NASDAQ: TXG) (the “Company”) today announced the pricing of an upsized underwritten public offering by the Company of its...
September 08, 2020 16:20 ET | Source: 10x Genomics, Inc.

10x Genomics Announces Launch of a Follow-On Public Offering

PLEASANTON, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (NASDAQ: TXG) (the “Company”) today announced that the Company has commenced an underwritten public offering of 3,500,000...
September 01, 2020 16:03 ET | Source: 10x Genomics, Inc.

10x Genomics to Participate in the Morgan Stanley 2020 Healthcare Conference

PLEASANTON, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare Conference. 10x...
August 11, 2020 16:05 ET | Source: 10x Genomics, Inc.

10x Genomics Reports Second Quarter 2020 Financial Results

PLEASANTON, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the second quarter ended June 30, 2020. Recent Highlights Revenue was...
August 06, 2020 17:00 ET | Source: 10x Genomics, Inc.

10x Genomics to Participate in the UBS Genomics 2.0 and Medtech Innovations Summit

PLEASANTON, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced the company will be participating in the upcoming UBS Genomics 2.0 and Medtech Innovations Virtual...
July 14, 2020 09:00 ET | Source: 10x Genomics, Inc.

10x Genomics Launches Next Generation Immune Profiling Product to Combat COVID-19

PLEASANTON, Calif., July 14, 2020 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) strengthened the research toolkit of scientists around the globe today with the launch of its Chromium Single Cell...